Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms

Mirabegron has been registered as the first strong and selective agonist of the β3 receptor. It is currently used for relief of symptoms of overactive bladder (OAB). That onerous illness involving urgency and detrusor overactivity, that may be accompanied by incontinence, affects approx. 16% of the...

Full description

Bibliographic Details
Main Authors: Tomasz Aleksiewicz, Kamil Leis, Wojciech Świerczyński, Kacper Miętkiewicz, Katarzyna Litwin, Przemysław Gałązka
Format: Article
Language:English
Published: Kazimierz Wielki University 2018-08-01
Series:Journal of Education, Health and Sport
Subjects:
mirabegron
overactive bladder
review
Online Access:http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5864

Similar Items

Similar Items